188 related articles for article (PubMed ID: 37638660)
21. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
Liu X; Zhu X; Qi X; Meng X; Xu K
Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
[TBL] [Abstract][Full Text] [Related]
22. Synergistic Cascade Strategy Based on Modifying Tumor Microenvironment for Enhanced Breast Cancer Therapy.
Zhang H; Xu J; Gao B; Wang H; Huang J; Zhou J; Yang R; Yan F; Peng Y
Front Pharmacol; 2021; 12():750847. PubMed ID: 34867360
[No Abstract] [Full Text] [Related]
23. Oxygen Production of Modified Core-Shell CuO@ZrO
Chen Z; Niu M; Chen G; Wu Q; Tan L; Fu C; Ren X; Zhong H; Xu K; Meng X
ACS Nano; 2018 Dec; 12(12):12721-12732. PubMed ID: 30512923
[TBL] [Abstract][Full Text] [Related]
24. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
[TBL] [Abstract][Full Text] [Related]
25. Metal organic framework coated MnO
Nie Y; Li D; Peng Y; Wang S; Hu S; Liu M; Ding J; Zhou W
Int J Pharm; 2020 Jul; 585():119513. PubMed ID: 32526334
[TBL] [Abstract][Full Text] [Related]
26. H
Li S; Xu F; Ren X; Tan L; Fu C; Wu Q; Chen Z; Ren J; Huang Z; Meng X
ACS Nano; 2023 Oct; 17(19):19242-19253. PubMed ID: 37781935
[TBL] [Abstract][Full Text] [Related]
27. Amplified intracellular Ca
Dou JP; Wu Q; Fu CH; Zhang DY; Yu J; Meng XW; Liang P
J Nanobiotechnology; 2019 Dec; 17(1):118. PubMed ID: 31791353
[TBL] [Abstract][Full Text] [Related]
28. Ball-in-ball ZrO
Long D; Niu M; Tan L; Fu C; Ren X; Xu K; Zhong H; Wang J; Li L; Meng X
Nanoscale; 2017 Jun; 9(25):8834-8847. PubMed ID: 28632268
[TBL] [Abstract][Full Text] [Related]
29. Biomimetic Metal-Chalcogenide Agents Enable Synergistic Cancer Therapy via Microwave Thermal-Dynamic Therapy and Immune Cell Activation.
Xu X; Wu Q; Tan L; Men X; Huang Y; Li H
ACS Appl Mater Interfaces; 2023 Sep; 15(36):42182-42195. PubMed ID: 37651685
[TBL] [Abstract][Full Text] [Related]
30. A multifunctional nanoplatform for improving microwave hyperthermia by a combination therapy of vessel disruptive agent and immune modulator.
Zeng Z; Sun X; Huang Z; Fu C; Ren J; Niu M; Tan L; Ren X; Wu Q; Meng X
Colloids Surf B Biointerfaces; 2022 Sep; 217():112616. PubMed ID: 35759896
[TBL] [Abstract][Full Text] [Related]
31. A multifunctional metal-organic framework nanosystem disrupts redox homeostasis for synergistic therapy.
Sun Y; Du X; Liang J; Wang D; Zheng J; Bao Z; Zhao Z; Yuan Y
J Colloid Interface Sci; 2023 Sep; 645():607-617. PubMed ID: 37167910
[TBL] [Abstract][Full Text] [Related]
32. Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor.
Phua SZF; Yang G; Lim WQ; Verma A; Chen H; Thanabalu T; Zhao Y
ACS Nano; 2019 Apr; 13(4):4742-4751. PubMed ID: 30964974
[TBL] [Abstract][Full Text] [Related]
33. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress.
Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803
[TBL] [Abstract][Full Text] [Related]
34. A nanoscale photothermal agent based on a metal-organic coordination polymer as a drug-loading framework for effective combination therapy.
Li J; Zhang C; Gong S; Li X; Yu M; Qian C; Qiao H; Sun M
Acta Biomater; 2019 Aug; 94():435-446. PubMed ID: 31216493
[TBL] [Abstract][Full Text] [Related]
35. A Novel Instantaneous Self-Assembled Hollow MOF-Derived Nanodrug for Microwave Thermo-Chemotherapy in Triple-Negative Breast Cancer.
Wu Q; Li T; Song J; Sun X; Ren X; Fu C; Chen L; Tan L; Niu M; Meng X
ACS Appl Mater Interfaces; 2022 Nov; 14(46):51656-51668. PubMed ID: 36355432
[TBL] [Abstract][Full Text] [Related]
36. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
Lv W; Cao M; Liu J; Hei Y; Bai J
Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
[TBL] [Abstract][Full Text] [Related]
37. Enhanced Photodynamic Therapy by Reduced Levels of Intracellular Glutathione Obtained By Employing a Nano-MOF with Cu
Zhang W; Lu J; Gao X; Li P; Zhang W; Ma Y; Wang H; Tang B
Angew Chem Int Ed Engl; 2018 Apr; 57(18):4891-4896. PubMed ID: 29451722
[TBL] [Abstract][Full Text] [Related]
38. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
[TBL] [Abstract][Full Text] [Related]
39. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
40. A natural polysaccharide mediated MOF-based Ce6 delivery system with improved biological properties for photodynamic therapy.
Fu X; Yang Z; Deng T; Chen J; Wen Y; Fu X; Zhou L; Zhu Z; Yu C
J Mater Chem B; 2020 Feb; 8(7):1481-1488. PubMed ID: 31996879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
